Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Have Declined -5.10% YTD, Forecasting What Will Happen Next
Arcutis Biotherapeutics Inc (NASDAQ:ARQT)’s traded shares stood at 3.95 million during the last session, with the company’s beta value hitting 1.51. At the close of